Trials / Unknown
UnknownNCT02325999
Endoscopic Submucosal Dissection Combine With Laparoscopic Regional Lymph Node Dissection for Early Gastric Cancer
Endoscopic Submucosal Dissection Combine With Laparoscopic Regional Lymph Node Dissection:a New Therapy for Early Gastric Cancer
- Status
- Unknown
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Beijing Friendship Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether Endoscopic Submucosal Dissection combine with Laparoscopic Regional Lymph node Dissection for early gastric cancer can improve Disease-free survival ？
Detailed description
Patients with early stage of gastric cancer(T1a/T1bN0M0,NCCN2014.V1) will depart into two group randomized double-blind, then experimental group accept Endoscopic Submucosal Dissection combine with Laparoscopic Regional Lymph node Dissection ,and control group accept Endoscopic Submucosal Dissection only.The follow-up time is from operation to recrudescence.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | ESD AND LRLD | A new therapy for gastric cancer : Endoscopic Submucosal Dissection combine with Laparoscopic Regional Lymph node Dissection. |
Timeline
- Start date
- 2013-12-01
- Primary completion
- 2018-12-01
- Completion
- 2019-12-01
- First posted
- 2014-12-25
- Last updated
- 2014-12-25
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02325999. Inclusion in this directory is not an endorsement.